We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » First-in-Human Cancer Trials Subject of ICH Guidance
First-in-Human Cancer Trials Subject of ICH Guidance
February 18, 2009
Sponsors of cancer drugs can include maximum tolerated doses and dose-limiting toxicity in Phase I clinical trials, an International Conference on Harmonisation (ICH) draft guidance says.